This Chandler guide tells you who pays for it

The clinic group pays for this guide

The clinic group that may receive your appointment request paid for this guide. The same group runs the nearby QC Kinetix offices, so it may make money if you book care. You deserve to know that.

That payment doesn't show whether a treatment will help your back. Your symptoms, medicines, other health needs, and budget still need a personal review. Your doctor may suggest a different kind of care, and that can be the right answer.

For clarity about the service, QC Kinetix offers non-surgical regenerative treatments, a clinic term for care such as a concentrated PRP shot prepared by spinning your blood and given by a trained health worker. The hoped-for result is less soreness, but no result is promised. Ask whether a doctor, nurse, or another health worker will examine you, so you'll know who is responsible.

This guide doesn't rank clinics or promise relief. Prices and health-plan rules can change, so check both before paying. During an urgent problem, call for medical help instead of reading further. That's the safest choice.

Sources

1. The only double-blind randomised trial of intradiscal PRP for discogenic low back pain enrolled 47 participants (29 PRP, 18 control) and reported statistically significant improvements in pain, function and satisfaction over EIGHT WEEKS compared with a contrast-agent control. It is a small, single-centre trial, the control group was offered crossover to PRP at 8 weeks, and no disc infection, neurological injury or progressive herniation was reported. The authors themselves call the results promising and say further studies are needed to define who responds.

   Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, et al. — Lumbar Intradiskal Platelet-Rich Plasma (PRP) Injections: A Prospective, Double-Blind, Randomized Controlled Study.. PM&R, 2016. DOI: 10.1016/j.pmrj.2015.08.010.

2. A follow-up of a SUBSET of patients from that intradiscal PRP trial, contacted once at 5-9 years post-injection, reported statistically and clinically significant improvements in pain and function versus their own baseline. Six patients had gone on to surgery during the interval. This is an uncontrolled long-term look at a subset, not a controlled comparison, and cannot separate treatment effect from natural history.

   Cheng J, Santiago KA, Nguyen JT, Solomon JL, Lutz GE — Treatment of symptomatic degenerative intervertebral discs with autologous platelet-rich plasma: follow-up at 5-9 years.. Regenerative Medicine, 2019. DOI: 10.2217/rme-2019-0040.

3. The 2025 ASIPP regenerative-therapy guideline for chronic low back pain - written by the specialty society that performs these procedures - grades the evidence as Level III (fair) for intradiscal PRP, Level III (fair) for intradiscal bone marrow concentrate, Level III (fair) for epidural PRP, Level IV (limited) for facet joint PRP and MSC injections, Level IV (limited) for sacroiliac joint PRP, and very low for functional-spine-unit injections. All 19 recommendations are consensus-based rather than evidence-driven, the panel names the scarcity of high-quality studies as the primary limitation, and it states that most of these therapies are not covered by commercial insurance.

   Manchikanti L, Navani R, Navani A, et al. — Comprehensive Evidence-Based Guidelines for Regenerative Therapies in the Management of Chronic Low Back Pain: 2025 Update from the American Society Of Interventional Pain Physicians (ASIPP).. Pain Physician, 2025.

4. CMS covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and then only inside an approved coverage-with-evidence-development clinical study. There is no national Medicare coverage for PRP in low back pain of any origin, and commercial plans generally follow with musculoskeletal PRP non-coverage policies.

   Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma - Coverage with Evidence Development.. CMS.gov, 2025.